Research progress on intralymphatic immunotherapy
10.3760/cma.j.issn.1673-0860.2018.08.015
- VernacularTitle: 淋巴结内免疫治疗研究进展
- Author:
Lingjun RONG
1
;
Jun ZHENG
1
;
Jinqi LANG
1
;
Cuida MENG
1
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, China
- Publication Type:Review
- Keywords:
Immunotherapy;
Lymph nodes
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2018;53(8):628-630
- CountryChina
- Language:Chinese
-
Abstract:
Intralymphatic immunotherapy (ILIT) is an effective and safe causative treatment for allergic diseases. Compared with conventional specific immunotherapy such as subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), ILIT could significantly reduce treatment duration. This article will review the results of previous researches focusing on ILIT.
